How ELTON Works: From Discovery to Continuous Monitoring

An Integrated Cybersecurity Platform Built for Regulatory Reality

Modern medical device cybersecurity is no longer about running isolated tests or producing static reports. Regulators now expect traceability, context, and continuous justification across the entire product lifecycle. That is exactly why ELTON was designed as an integrated platform where discovery, testing, analysis, monitoring, and optimization are tightly connected and directly mapped to regulatory expectations.

Below is how ELTON’s core capabilities interrelate to deliver defensible, audit ready cybersecurity outcomes.

Discover: Building the Digital Twin

Regulatory alignment includes FDA Premarket Cybersecurity Guidance, IEC 81001-5-1, and Secure Product Development Framework expectations.

Cybersecurity context starts with architecture. ELTON begins by creating a digital twin of the product that captures components, data flows, trust boundaries, assets, and security controls. This information is transformed into a graph model, allowing vulnerabilities to be tied to specific components and paths through the system rather than existing as disconnected findings.

This discovery phase establishes the technical foundation regulators expect manufacturers to demonstrate. It shows clear understanding of system design, attack surfaces, and where cybersecurity risks can realistically manifest.

Identify: Executing and Correlating Testing

Regulatory alignment includes FDA vulnerability identification expectations, SBOM requirements, penetration testing, and static and dynamic analysis. ELTON provides testing as a continuous subscription service to feed key vulnerability data to the ELTON platform.

Once the digital twin exists, ELTON executes and integrates multiple sources of vulnerability data. This includes penetration testing results, SAST and DAST findings, SBOM derived CVEs, configuration weaknesses, and real time risk intelligence. All findings are normalized into a common data model and directly linked back to the digital twin.

By correlating these sources instead of treating them independently, ELTON ensures that vulnerabilities are complete, non duplicative, and traceable to specific system elements. This satisfies regulatory expectations that manufacturers demonstrate comprehensive identification across software, firmware, hardware, and interfaces.

Contextualize: Turning Findings into Meaningful Risk

Regulatory alignment includes FDA vulnerability assessment criteria, MDDT aligned scoring methodologies, and postmarket risk evaluation requirements.

Raw vulnerability data alone is not sufficient for regulatory or business decisions. ELTON contextualizes each finding by mapping it to the system architecture, adjusting severity based on real exposure, and correlating related vulnerabilities across components. This includes evaluating chained exploitability, where multiple lower severity issues together create a credible attack path.

Rather than inflating or suppressing scores arbitrarily, ELTON produces adjusted ratings that reflect how the product actually operates in the field. This enables manufacturers to justify why certain vulnerabilities require remediation, compensating controls, or ongoing monitoring, which is a critical expectation in FDA reviews and audits.

Monitor: Continuous Cybersecurity Over the Product Lifecycle

Regulatory alignment includes FDA Postmarket Cybersecurity Guidance, total product lifecycle requirements, and ongoing SBOM monitoring.

Cybersecurity does not end at release. ELTON continuously monitors materials, vulnerability intelligence, and posture changes throughout the commercial life of each product release. As new vulnerabilities emerge or system context changes, ELTON reassesses affected components and updates risk ratings accordingly.

This continuous monitoring ensures that vulnerability management remains current, traceable, and aligned to the specific commercial release under review. It directly supports regulatory expectations for ongoing risk management and vulnerability metrics rather than point in time assessments.

Optimize: Enabling Informed Remediation Decisions

Regulatory alignment includes risk based remediation justification, CAPA support, and audit defensibility.

ELTON goes beyond identification and monitoring by enabling optimization through scenario analysis. Manufacturers can perform what if analyses to evaluate packages of vulnerabilities and understand how fixing specific issues would impact overall product posture. This allows teams to prioritize remediation efforts that meaningfully reduce risk while avoiding unnecessary or disruptive changes.

From a regulatory standpoint, this capability supports defensible decision making. It provides clear rationale for remediation strategies, deferred fixes, or acceptance decisions backed by data, architecture context, and documented impact.

One Platform, One Defensible Story

Taken together, ELTON’s Discover, Identify, Contextualize, Monitor, and Optimize capabilities form a single, continuous system. Each capability feeds the next, creating a closed loop cybersecurity program that aligns technical reality with regulatory expectations.

The result is not just better security, but clearer justification, stronger audit outcomes, and a sustainable approach to maintaining compliant medical devices throughout their lifecycle.